Harm-reduction protocol
Stimulant Defense Stack
People using methamphetamine or other high-dose stimulants who want to reduce the physical damage while they are still using.
Read this first. Nothing on this page offsets the exposure. Every item below reduces damage at the margins while the exposure continues — that is the whole claim, and it is a modest one. The honest comparison: in the heart-failure literature, abstinence is the intervention associated with recovery, and the degree of structural damage at the time of stopping predicts how much function returns. No supplement in this stack has been shown to do that. What follows reduces some of the oxidative cost and protects some of the organ systems most at risk — it does not substitute for the one variable with a documented effect on outcomes.
- Manja et al., Heart 2023 — Abstinence associated with improved heart-failure outcomes; extent of recovery predicted by chamber dimensions and fibrosis at baseline.
- Protocol items, each graded5
- Supplements to actively avoid3
- Markers worth tracking5
Do not take these
These appear before the protocol on purpose. Getting this part wrong does more harm than getting the rest of the page right does good.
Never combine a stimulant with a serotonergic supplement
This is the line most likely to prevent a death on this page. 5-HTP, L-tryptophan at supplement doses, St John's wort, SAM-e and high-dose dextromethorphan all raise serotonergic tone. Methamphetamine is itself a potent serotonin releaser. Combining them risks serotonin syndrome — hyperthermia, rigidity, autonomic instability, seizures — which is a medical emergency and can be fatal. The fact that these are sold without prescription does not make them safe in this combination. The same applies to MAOI-active botanicals such as Syrian rue and any "mood support" blend that does not fully disclose its ingredients.
Do not stack additional stimulants
High-dose caffeine, yohimbine, synephrine, ephedra-type botanicals and "pre-workout" blends add cardiovascular load on top of an already-strained heart. Given that cardiomyopathy is the leading cause of death in this group, this is a direct additive risk, not a theoretical one.
- Manja et al., Heart 2023 — Methamphetamine-associated heart failure burden and outcomes.
Hyperthermia is the acute emergency — plan for it
Overheating is a central mechanism of acute stimulant toxicity and neuronal injury, and it compounds in hot rooms, crowded spaces and with exertion. Practical mitigation matters more than any capsule here: keep fluids and electrolytes available, stay somewhere you can cool down, and treat confusion, stopping sweating, or a body temperature that feels dangerously high as an emergency requiring cooling and medical help, not something to sleep off.
- Halpin et al., Life Sci 2014 — Hyperthermia as a contributor to methamphetamine neurotoxicity.
What continuing actually costs
Dopaminergic terminal damage is the signature injury
High-dose methamphetamine damages dopamine and serotonin nerve terminals, with oxidative stress and reactive species central to the mechanism rather than incidental to it. This is the basis for every antioxidant strategy below — and also the reason those strategies are inherently partial, since they act on one arm of a multi-arm injury that includes hyperthermia, excitotoxicity and mitochondrial failure.
- Halpin et al., Life Sci 2014 — Review of methamphetamine and MDMA neurotoxicity mechanisms.
- Yamamoto & Raudensky, Crit Rev Neurobiol 2005 — Amphetamine neurotoxicity as both cause and consequence of oxidative stress.
The heart is the most likely thing to kill you, and it is partly reversible
Methamphetamine-associated heart failure is common enough to have its own literature, and up to 44% of cases present with preserved ejection fraction — meaning it can be well advanced before the obvious signs appear. The part worth knowing: abstinence is associated with improved outcomes, and chamber dimensions and biopsy fibrosis predict how much recovery is possible. Damage accumulated so far is not necessarily permanent, but the window is not open indefinitely.
- Manja et al., Heart 2023 — Systematic review of methamphetamine-associated heart failure: up to 44% with preserved LVEF; abstinence and guideline-directed therapy associated with improved outcomes; chamber size and fibrosis predict extent of recovery.
- Somma et al., Intern Med J 2023 — Methamphetamine-associated cardiomyopathy from an addiction-medicine perspective.
Dental destruction is fast, cheap to slow, and permanent if ignored
Rampant caries in stimulant users is driven by a combination of xerostomia, sugar intake, bruxism and deferred care — most of which are addressable without stopping use. Of everything on this page, the dental protocol has the best ratio of effort to preserved quality of life.
- Ravenel et al., Quintessence Int 2012 — Pilot study characterising the caries pattern of "meth mouth".
- Teoh et al., Aust Dent J 2019 — Oral manifestations of illicit drug use.
The protocol
Ordered by strength of evidence, not by cost or convenience. Each tier note says what the grade rests on, so you can judge it rather than take it on trust.
N-acetylcysteine (NAC)
Tier C· Preclinical- Dose
- 1,200–2,400 mg/day
- Timing
- Split morning and evening
Included as a glutathione precursor for the oxidative-stress arm of the injury — NOT as a treatment for use or craving. Read the tier note before deciding, because the trial evidence here is genuinely mixed and the largest study was negative.
Why this grade: Tier C, and deliberately so. The largest and best-powered trial — 153 methamphetamine-dependent participants, 2,400 mg/day for 12 weeks — found NO effect on days of use, craving, dependence severity, withdrawal or psychiatric symptoms versus placebo. A smaller crossover trial did find reduced craving, and a 2024 meta-analysis across substance use disorders found a modest craving effect while explicitly describing the evidence as weak. NAC is kept in this stack for glutathione support, which is a different and much more modest claim than the one most pages make for it.
- McKetin et al., EClinicalMedicine 2021 (N-ICE) — NEGATIVE — NAC 2,400 mg/day for 12 weeks, n=153: no significant effect on methamphetamine use, craving, dependence severity, withdrawal, or psychiatric symptoms versus placebo.
- Mousavi et al., Arch Iran Med 2015 — Smaller double-blind crossover trial, 1,200 mg/day: reduced craving scores (23 completers).
- Cuocina et al., Front Pharmacol 2024 — Meta-analysis of 11 RCTs across substance use disorders: craving reduced (SMD −0.61), authors state the evidence is weak.
Vitamin C
Tier C· Preclinical- Dose
- 500–1,000 mg/day
- Timing
- Split with meals
Cheap, water-soluble, and directed at the same oxidative arm. Stimulant use is typically accompanied by poor dietary intake, so this is often correcting a real deficit rather than supplementing an adequate one.
Why this grade: Tier C. Mechanistically coherent and low-risk; no trial in stimulant users has tested a hard endpoint.
R-alpha-lipoic acid
Tier C· Preclinical- Dose
- 300–600 mg/day
- Timing
- Away from food
Regenerates other antioxidants and is both water- and fat-soluble, so it reaches compartments ascorbate does not. Chosen over generic ALA for the active isomer.
Why this grade: Tier C. Lipoic acid has real human trial data in diabetic neuropathy, but nothing has tested it in stimulant users and the neuropathy evidence does not transfer to this exposure. Included on redox rationale, graded accordingly.
Magnesium (glycinate)
Tier C· Preclinical- Dose
- 200–400 mg elemental/day
- Timing
- Evening
Targets the things most likely to be depleted and most likely to hurt: sleep debt, bruxism that is destroying teeth, and cardiac irritability. The glycinate form is chosen for tolerability and because glycine is useful here on its own account.
Why this grade: Tier C for this use. Magnesium repletion is well established generally; nothing has tested it in stimulant users specifically.
CoQ10 (ubiquinone)
Tier C· Preclinical- Dose
- 100–200 mg/day
- Timing
- With a fat-containing meal
Directed at the cardiac and mitochondrial arm rather than the neurological one, given that cardiomyopathy is the highest-mortality complication in this population.
Why this grade: Tier C. Extrapolated from general heart-failure literature, not from stimulant users.
Interactions and cautions
Water intoxication is a real risk in the other direction
Drinking large volumes of plain water to counter dehydration can drop sodium dangerously, particularly alongside the antidiuretic effects of some stimulants. Use electrolyte-containing fluid rather than water alone, and drink to thirst rather than on a schedule.
What to actually track
| Marker | Why it matters | Cadence |
|---|---|---|
| Blood pressure and resting heart rate | The earliest signal of the complication most likely to be fatal | Weekly at home |
| Echocardiogram | Methamphetamine cardiomyopathy can be advanced with preserved ejection fraction — symptoms are a late signal | Ask for one; repeat per cardiology advice |
| Dental review | Caries progression is fast and, once through the enamel, irreversible | Every 6 months, sooner if there is pain |
| Renal function and CK | Rhabdomyolysis and kidney injury follow hyperthermia and dehydration episodes | After any overheating episode; otherwise annually |
| Weight and albumin | Undernutrition drives much of the visible deterioration and is directly fixable | Monthly |
This page is educational and is not medical advice. It does not diagnose or treat anything, and it is not a substitute for a clinician who knows your history — which matters more here than on most pages, because several items above interact with prescription medicines. If you want help stopping rather than mitigating, that is a better outcome than anything on this page can deliver, and it is worth asking for. How TNiC grades evidence →